Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News on Pharma

India takes first step to remove animals from drug-testing process

Every drug in the market goes through a long journey of tests, each designed to check whether it can treat the disease for which it was created and whether it has any unintended harmful effects. For a long time, the first step of this process was to test the candidate…

The Hindu

2 Biotech Stocks to Buy, 1 to Sell Now

The biotech industry is well-positioned for long-term growth thanks to increasing demand for quality healthcare, a rapidly aging population, and rising chronic diseases. Therefore, buying fundamentally strong biotech stocks Entrada Therapeutics (TRDA) and ProQR Therapeutics N.V. (PRQR) could be wise. On the other hand, one should consider selling 4D Molecular…

StockNews.com

3 Medical Stocks to Buy for Great Value

Owing to the rising prevalence of chronic medical conditions and awareness among the patient population, the medical industry is poised for remarkable growth. Therefore, it could be wise to scoop up the shares of quality medical stocks Medtronic plc (MDT), FONAR Corporation (FONR), and Electromed, Inc. (ELMD), which carry significant…

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Biotech Stocks With Some Major Value in Them

The worldwide need for healthcare and biotech products is experiencing a steady upsurge fueled by various factors, such as a heightened emphasis on personalized medicine. Therefore, it could be wise to explore three quality biotech stocks, Gilead Sciences (GILD), Biogen (BIIB), and Alkermes (ALKS), with significant value in them. Read…

StockNews.com

Canada's misguided changes to drug regulation could fast-track unproven medications and divert funds from other health needs

The Canadian government is proposing a new “Agile Licensing” framework to expedite pre-market regulation of pharmaceuticals. While Health Minister Jean-Yves Duclos claims this is part of the government’s strategy to offer Canadians “access to quality and affordable medicines,” the policy is likely to cause more harm than good.

The Conversation

Moderna Stock Rises After FDA Application For Updated Vaccine

Moderna's potential beyond COVID-19 is underappreciated, says analyst Eliana Merle, who upgraded the stock to Buy

Zenger

North East deals of the week: key acquisitions, contracts and investments

Companies featuring in this week's round-up include Max Purpose Psychology, Parker Bioscience Filtration, Ward Investments Group, Newcastle Building Society and Talk Works

Birmingham Post

Read news from The Economist, FT, and more,
with one subscription

Should France guarantee supply of abortion drugs by producing its own?

One of two abortion pills has been added to the list of drugs France considers essential, but it is not among 50 medications that President Emmanuel Macron says will soon be produced locally – even despite a recent shortage that raised questions about France's ability to guarantee the right to…

Radio France Internationale

GSK settles lawsuit over heartburn drug allegedly linked to cancer

The drug was owned by GSK but distribution was halted and it was recalled in 2019

Wales Online

Parker Hannifin makes multimillion-dollar investment into Birtley Bioscience Filtration site

The investment comes as the firm sees growing demand from the pharmaceutical, biopharmaceutical, and food and beverage industries

Birmingham Post

GOP aims to use budget to limit abortion

On top of sweeping state abortion bans, the GOP has been pursuing less-publicized federal anti-abortion moves

Salon

Moderna (MRNA) vs. BioNTech (BNTX): Which Biotech Stock Should You Be Investing In?

Amidst the biotech industry’s rapid growth and notable advancements, let’s analyze which of the two major players, Moderna (MRNA) and BioNTech (BNTX), is a more favorable investment choice in the current uncertain economic climate. Keep reading to find out.

StockNews.com

AstraZeneca considers spinning off its China business

UK’s largest stock-market-listed firm weighs up Hong Kong or Shanghai listing to shield it from geopolitical tensions

The Guardian - UK

What CVS stands for throws shoppers as they joke about drugstore's 'government name'

CVS is a household name in the US but finding out in it's an acronym confused many and then finding out what the initials stood for really baffled them

Daily Mirror

Get all your
news in one place.

100's of premium titles.
One news app.

Los Angeles Times

Michael Hiltzik: Merck says it's being 'coerced' into negotiating its drug prices with Medicare. That's nonsense

No one really expected the pharmaceutical industry to lie down and take it when Congress authorized Medicare to start negotiating prices of the prescription drugs it buys for enrollees.

The Independent UK

New Zealand seizes 713kg meth hidden in maple syrup from Canada

‘It’s kind of sad in some ways that we keep coming and saying we’re getting bigger and bigger seizures’

Tribune News Service

Medtronic weighs appeal after losing patent case regarding catheter technology

MINNEAPOLIS — Medtronic is weighing its next steps after losing another round in a long-running patent dispute with med-tech competitor Teleflex Inc.

StockNews.com

3 Biotech Stocks With Great Value

The global demand for healthcare and biotech products continues to grow, owing to factors such as increasing chronic diseases and a greater focus on personalized medicine. Therefore, it might be wise to check out fundamentally sound biotech stocks BioMarin Pharmaceutical (BMRN), Exelixis, Inc. (EXEL), and Theratechnologies (THTX), currently trading at…

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

Tilray Brands (TLRY) vs. Novo Nordisk (NVO): Which Pharma Stock Should You Buy?

The pharmaceutical sector performs relatively well during economic uncertainties due to inelastic demand for its products and services. While prominent players Tilray Brands (TLRY) and Novo Nordisk (NVO) should benefit, which stock is the better buy now? Read more to find out.

Radio France Internationale

Macron promises to bring pharmaceutical production 'back home' to France

French President Emmanuel Macron has vowed to relocate the production of 50 key pharmaceutical drugs, 25 of them - in the coming weeks - to tackle an ongoing shortage of medicines in France.

StockNews.com

Should You Buy Into Pfizer (PFE) Today?

Despite a slowdown of Covid-19 vaccine sales in the last reported quarter, biopharmaceutical giant Pfizer (PFE) is positioned to deliver robust growth this year and beyond, thanks to the strength of its in-line products and expected near-term launches and revenue distribution from the recent acquisition. So, let’s find out if…

StockNews.com

2 Game-Changing Biotech Stocks, 1 to Sell Now

As the biotech industry looks well-positioned for solid growth driven by strong government support and a growing foothold of personalized medicines, it could be wise for investors to buy fundamentally strong biotech stocks Gilead Sciences (GILD) and Regeneron Pharmaceuticals (REGN). However, fundamentally weak Titan Pharmaceuticals (TTNP) might be best avoided.…

Birmingham Post

Pharma firm Quantum sees big increase in revenues and profits

The County Durham company said it was focussed on growth after a successful year

StockNews.com

Is Catalyst Pharmaceuticals (CPRX) a Buy in the Near Future?

Catalyst Pharmaceuticals (CPRX) witnessed significant bottom-line growth in the first quarter but missed expectations. Does the biopharmaceutical company deserve a place in your portfolio in the near future? Let’s look at its financial metrics to get an idea….

Newsroom.co.nz

Advocating for climate justice

As part of a weekly showcase of future leaders and inspirational young New Zealanders from the Hyundai Pinnacle Programme, Isla Day wants to develop better connections between industry and academia in the field of drug development – and fight for climate justice | Content Partnership

1 … 51 52 53 54

People

Dipanjan BanchurSince

722 stories

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Health and Human Services

285 stories

MRNA

220 stories

Australian Federal Police

219 stories

GILD

215 stories

the Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.